Neuroendocrinology
Regulation of Hypothalamic Neurons
Rapid Stimulatory Effects of Brain-Derived Neurotrophic Factor and Neurotrophin-3 on Somatostatin Release and Intracellular Calcium Rise in Primary Hypothalamic Cell CulturesMarmigère F.a · Choby C.b · Rage F.a · Richard S.b · Tapia-Arancibia L.aaLaboratoire de Plasticité Cérébrale, UMR 5102 CNRS, Université Montpellier 2, CC 090, et bIGH, UPR 1142 CNRS, Montpellier, France
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: July 06, 2001
Issue release date: July 2001
Number of Print Pages: 12
Number of Figures: 9
Number of Tables: 3
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
Although the long-lasting effects of neurotrophins have been extensively studied, less data are available on their rapid effects, especially on peptide release. In the present report, we investigated rapid effects of neurotrophins on somatostatin release and on intracellular calcium concentration ([Ca2+]i) in primary cultures of hypothalamic neurons. RT-PCR experiments revealed mRNA expression of the three high-affinity neurotrophin receptors tyrosine kinase (Trk) TrkA, TrkB and TrkC, indicating potential responses to their preferential ligands: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), respectively. We demonstrated that BDNF, and to a lesser extent NT-3, induced significant time- and concentration-dependent somatostatin release, while NGF was devoid of any effect. BDNF or NT-3 induction of somatostatin release was inhibited by the Trk inhibitors K-252a and genistein, whereas K-252b, a less effective inhibitor, had no effect. BDNF- and NT-3-induced somatostatin release depended upon extra- and intracellular Ca2+ since it was completely abolished in the presence of the Ca2+ chelators BAPTA (bis-(α-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic acid) or BAPTA-AM (bis-(α-aminophenoxy)-ethane-N,N,N′,N′-tetraacetoxymethylester), respectively. In addition, BDNF and NT-3 induced a sustained and rapid increase in [Ca2+]i which depended on the extracellular Ca2+ concentration. MK-801 (dizocilpine) and tetrodotoxin (TTX) entirely blocked neurotrophin-evoked somatostatin release and [Ca2+]i rise in response to BDNF and NT-3 application in most neurons. Neurotrophin-induced [Ca2+]i rise was completely blocked by K-252a. The present results are consistent with: (1) an indirect effect of neurotrophins on somatostatin release via endogenous glutamate release and subsequent NMDA receptor activation, (2) a major indirect effect of neurotrophins on Ca2+ rise in hypothalamic neurons which very likely occurs through NMDA receptor activation. Taken altogether, these results indicate that BDNF and NT-3 can rapidly affect the activity of hypothalamic neurons.
© 2001 S. Karger AG, Basel
Related Articles:
References
-
Lai KO, Fu WY, Ip FCF, Ip NY: Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 1998;11:64–76.
- Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289–317.
- Nilsson AS, Fainzilber M, Falck P, Ibanez CF: Neurotrophin-7: A novel member of the neurotrophin family from the zebrafish. FEBS Lett 1998;424:285–290.
- Chao MV, Hempstead BL: p75 and Trk: A two-receptor system. Trends Neurosci 1995;18:321–326.
- Castrén E, Thoenen H, Lindholm D: Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 1995;64:71–80.
- Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD: NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron 1990;5:501–509.
- Korsching S, Auburger G, Heumann R, Scott J, Thoenen H: Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 1985;4:1389–1393.
- Katoh-Semba R, Takeuchi IK, Semba R, Kato K: Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 1997;69:34–42.
- Nawa H, Carnahan J, Gall C: BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur J Neurosci 1995;7:1527–1535.
- Loudes C, Petit F, Kordon C, Faivre-Bauman A: Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). Eur J Neurosci 1999;11:617–624.
- Marmigère F, Rage F, Tapia-Arancibia L, Arancibia S: Expression of mRNAs encoding BDNF and its receptor in adult rat hypothalamus. Neuroreport 1998;9:1159–1163.
- Lapchak PA, Araujo DM, Carswell S, Hefti F: Distribution of [125I] nerve growth factor in the rat brain following a single intraventricular injection: Correlation with the topographical distribution of trkA messenger RNA-expressing cells. Neuroscience 1993;54:445–460.
- Merlio JP, Ernfors P, Jaber M, Persson H: Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 1992;51:513–532.
- Rage F, Riteau B, Alonso G, Tapia-Arancibia L: Brain-derived neurotrophic factor and neurotrophin-3 enhance somatostatin gene expression through a direct effect on somatostatin neurons in hypothalamic neurons. Endocrinology 1999;140:909–916.
- Barnea A, Cho G, Lu G, Mathis M: Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide-Y-producing neurons. J Neurosci Res 1995;42:638–647.
- Nawa H, Bessho Y, Carnahan J, Nakanishi S, Mizuno K: Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J Neurochem 1993;60:772–775.
- Rutherford LC, DeWan A, Lauer HM, Turrigiano GG: Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. J Neurosci 1997;17:4527–4535.
- Berninger B, Poo MM: Fast actions of neurotrophic factors. Curr Opin Neurobiol 1996;6:324–330.
- Knipper M, Leung LS, Zhao D, Rylett RJ: Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. Neuroreport 1994;5:2433–2436.
- Lessmann V, Gottmann K, Heumann R: BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurons. Neuroreport 1994;6:21–25.
- Levine ES, Dreyfus CF, Black IB, Plummer MR: Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci USA 1995;92:8074–8077.
- McAllister AK, Katz LC, Lo DC: Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999;22:295–318.
- Schuman E: Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 1999;9:105–109.
- Knipper M, Berzaghi MdP, Blöchl A, Breer H, Thoenen H, Lindholm D: Positive feedback between acetylcholine and neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus. Eur J Neurosci 1994;6:668–671.
- Kafitz KW, Rose CR, Thoenen H, Konnerth A: Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999;401:918–921.
- Tapia-Arancibia L, Astier H: Glutamate stimulates somatostatin release from diencephalic neurons in primary culture. Endocrinology 1988;123:2360–2366.
- Dayanithi G, Tapia-Arancibia L: Rise in intracellular calcium via a non-genomic effect of allopregnanolone in fetal rat hypothalamic neurons. J Neurosci 1996;16:130–136.
- Bottenstein JE, Sato GH: Growth of neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979;76:514–517.
- Rage F, Alonso G, Tapia-Arancibia L: Stimulatory effect of N-methyl-D-aspartate on somatostatin gene expression in cultured hypothalamic neurons. Mol Brain Res 1993;17:287–294.
- Elkabes S, Schaar DG, Dreyfus CF, Black IB: Developmental regulation of neurotrophin-3 and Trk C splice variants in optic nerve glia in vivo. Neuroscience 1995;66:879–889.
- Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440–3450.
- Gysembergh A, Lemaire S, Piot C, Sportouch C, Richard S, Kloner RA, Przyklenk K: Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart. Am J Physiol 1999;277:H2458–H2469.
- Knüsel B, Hefti F: K-252 compounds: Modulators of neurotrophin signal transduction. J Neurochem 1992;59:1987–1996.
- Koizumi S, Contreras ML, Matsuda Y, Hama T, Lazarovici P, Guroff G: K-252a: A specific inhibitor of the action of nerve growth factor on PC12 cells. J Neurosci 1988;8:715–721.
-
Benyassi A, Tapia-Arancibia L, Arancibia S: Glutamate periphally administered exerts somatostatin-releasing action in the conscious rat. J Neuroendocrinol 1991;3:429–432.
- Tapia-Arancibia L, Parès-Herbuté N, Astier H: Calcium dependence of somatostatin (SRIF) release and cyclic AMP levels in cultured diencephalic neurons. Neuroendocrinology 1989;49:555–560.
- Clapham DE: Calcium signaling. Cell 1995;80:259–268.
- Ghost A, Greenberg ME: Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science 1995;268:239–247.
- Berninger B, Garcia DE, Inagaki N, Hahnel C, Lindholm D: BDNF and NT-3 induce intracellular Ca2+ elevation in hippocampal neurons. Neuroreport 1993;4:1303–1306.
- Montcouquiol M, Valat J, Travo C, Sans A: Short-term response of postnatal rat vestibular neurons following brain-derived neurotrophic factor or neurotrophin-3 application. J Neurosci Res 1997;50:443–449.
- Blöchl A, Sirrenberg C: Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via trk and p75LNTR receptors. J Biol Chem 1996;271:21100–21107.
- Numakawa T, Takei N, Yamagishi S, Sakai N, Hatanaka H: Neurotrophin-elicited short-term glutamate release from cultured cerebellar granule neurons. Brain Res 1999;842:431–438.
- Takei N, Numakawa T, Kozaki S, Sakai N, Endo Y, Takahashi M, Hatanaka H: Brain-derived neurotrophic factor induces rapid and transient release of glutamate through the non-exocytotic pathway from cortical neurons. J Biol Chem 1998;273:27620–27624.
- Sala R, Viegi A, Rossi FM, Pizzorusso T, Bonanno G, Raiteri M, Maffei L: Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci 1998;10:2185–2191.
- Kang H, Schuman EM: Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995;267:1658–1662.
- Takei N, Sasaoka K, Inoue K, Takahashi M, Endo Y, Hatanaka H: Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats. J Neurochem 1997;68:370–375.
- Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS: Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 2000;3:323–329.
- He X, Yang F, Xie Z, Lu B: Intracellular Ca2+ and Ca2+/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3. J Cell Biol 2000;149:783–791.
- Desarmenien MG, Devic E, Rage F, Dayanithi G, Tapia-Arancibia L, Richard P: Synchronous development of spontaneous and evoked calcium-dependent properties in hypothalamic neurons. Dev Brain Res 1994;79:85–92.
- Dayanithi G, Rage F, Richard P, Tapia-Arancibia L: Characterization of spontaneous and N-methyl-D-aspartate-induced calcium rise in rat cultured hypothalamic neurons. Neuroendocrinology 1995;61:243–255.
- Vacaro DE, Messer A, Dichter MA, Leeman SE: Primary cultures of dispersed hypothalamic cells from fetal rats: Morphology, electrical activity, and peptide content. J Neurobiol 1980;11:417–424.
- Tazi A, Le Bras S, Lamghitnia HO, Vincent JD, Czernichow P, Scharfmann R: Neurotrophin-3 increases intracellular calcium in a rat insulin-secreting cell line through its action on a functional trkC receptor. J Biol Chem 1996;271:10154–10160.
- Pearce IA, Cambray-Deakin MA, Burgoyne RD: Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Lett 1987;223:143–147.
- Brewer GJ, Cotman CW: NMDA receptor regulation of neuronal morphology in cultured hippocampal neurons. Neurosci Lett 1989;99:268–273.
- Schwartz JP, Ji Z, Epelbaum J: Somatostatin as a neurotrophic factor – Which receptor/second messenger transduction system is involved? Perspect Dev Neurobiol 1998;5:427–435.
- White RE, Schonbrunn A, Armstrong DL: Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorilation. Nature 1991;351:570–573.
- Tallent MK, Siggins GR: Somatostatin depress excitatory but not inhibitory neurotransmission in rat Ca1 hippocampus. J Neurophysiol 1997;78:3008–3018.
- Lanneau C, Peineau S, Petit F, Epelbaum J, Gardette R: Somatostatin modulation of excitatory synaptic transmission between periventricular and arcuate hypothalamic nuclei in vitro. J Neurophysiol 2000;84:1464–1474.
- Zucker RS: Calcium- and activity-dependent synaptic plasticity. Curr Opin Neurobiol 1999;9:305–313.
Article / Publication Details
Published online: July 06, 2001
Issue release date: July 2001
Number of Print Pages: 12
Number of Figures: 9
Number of Tables: 3
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission